RESMED INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for RESMED INC (RMD), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are RMD insiders buying or selling?
In the last 12 months, RESMED INC insiders reported 0 open-market purchases ($0) and 30 sales ($22.0M) — net selling of $22.0M. Since January 2018, Trabud has recorded 433 Form 4 filings for RMD: 0 buys ($0) and 433 sells ($318.9M).
Source: SEC EDGAR Form 4
What stands out
- No RESMED INC insider made an open-market purchase in the last 12 months; the 30 reported open-market sales totaled $22.0M.
Key Statistics (January 2018 – Oct 8, 2026)
Total Form 4 filings
433
SEC EDGAR
Insider filers
20
Insider buys (0)
$0
Insider sells (433)
$318.9M
Insider sentiment
Net sellingNet insider flow of $318.9M in net selling since January 2018, and $22.0M in net selling over the last 12 months.
Recent RMD insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $226.33 | $1.1M | SEC ↗ |
| Sep 10, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $222.44 | $1.1M | SEC ↗ |
| Sep 4, 2026 | FARRELL PETER C | Director | Sale | 970 | $234.73 | $227.7K | SEC ↗ |
| Aug 11, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $205.69 | $1.0M | SEC ↗ |
| Aug 6, 2026 | FARRELL PETER C | Director | Sale | 8.0K | $225.00 | $1.8M | SEC ↗ |
| Jul 9, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $218.55 | $1.1M | SEC ↗ |
| Jun 9, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $193.96 | $968.1K | SEC ↗ |
| May 11, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $207.82 | $1.0M | SEC ↗ |
| Apr 9, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $225.50 | $1.1M | SEC ↗ |
| Apr 3, 2026 | Brett Sandercock | Chief Financial Officer | Sale | 1.0K | $224.31 | $224.3K | SEC ↗ |
| Apr 2, 2026 | FARRELL PETER C | Director | Sale | 2.0K | $225.00 | $450.0K | SEC ↗ |
| Mar 11, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $251.03 | $1.3M | SEC ↗ |
| Mar 5, 2026 | FARRELL PETER C | Director | Sale | 2.0K | $260.22 | $520.4K | SEC ↗ |
| Feb 10, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $273.78 | $1.4M | SEC ↗ |
| Feb 6, 2026 | FARRELL PETER C | Director | Sale | 2.0K | $251.31 | $502.6K | SEC ↗ |
| Feb 6, 2026 | Michael J Rider | Global General Counsel | Sale | 50 | $260.00 | $13.0K | SEC ↗ |
| Feb 3, 2026 | Brett Sandercock | Chief Financial Officer | Sale | 1.0K | $257.03 | $257.0K | SEC ↗ |
| Jan 9, 2026 | FARRELL PETER C | Director | Sale | 2.0K | $248.83 | $497.7K | SEC ↗ |
| Jan 8, 2026 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $248.46 | $1.2M | SEC ↗ |
| Jan 5, 2026 | Brett Sandercock | Chief Financial Officer | Sale | 1.0K | $241.75 | $241.8K | SEC ↗ |
| Jan 5, 2026 | Michael J Rider | Global General Counsel | Sale | 50 | $241.75 | $12.1K | SEC ↗ |
| Dec 9, 2025 | Michael J. Farrell | Chairman and CEO | Sale | 5.0K | $251.41 | $1.3M | SEC ↗ |
| Dec 4, 2025 | FARRELL PETER C | Director | Sale | 2.0K | $251.47 | $502.9K | SEC ↗ |
| Dec 2, 2025 | Michael J Rider | Global General Counsel | Sale | 50 | $244.16 | $12.2K | SEC ↗ |
| Dec 2, 2025 | Brett Sandercock | Chief Financial Officer | Sale | 1.0K | $244.16 | $244.2K | SEC ↗ |
Showing the 25 most recent of 433 Form 4 filings for RESMED INC.
Most active RMD insiders
- Brett Sandercock88 filings
- Michael J. Farrell69 filings
- David Pendarvis65 filings
- Robert Andrew Douglas52 filings
- James Hollingshead49 filings
Ask anything about RMD insider activity
Use Trabud's AI agent to query RESMED INC's Form 4 history in plain English — "Show me RMD CEO purchases this year" or compare it against any other ticker.
Open the AI agentRMD insider trading FAQ
Are RESMED INC insiders buying or selling?
In the last 12 months, RESMED INC insiders reported 0 open-market purchases ($0) and 30 sales ($22.0M) — net selling of $22.0M. Since January 2018, Trabud has recorded 433 Form 4 filings for RMD: 0 buys ($0) and 433 sells ($318.9M). Over the full record that is net selling of $318.9M.
How many insiders trade RMD stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for RESMED INC. The most recent filing was accepted on Oct 8, 2026.
Where does Trabud get RMD insider trading data?
All RMD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.